查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2023539

放射学领域人工智慧市场分析与预测（至2035年）：类型、服务、技术、应用、部署状态、最终用户、解决方案

AI In Radiology Market Analysis and Forecast to 2035: Type, Services, Technology, Application, Deployment, End User, Solution
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球放射学人工智慧市场预计将从2025年的320亿美元成长到2035年的2,491亿美元，复合年增长率（CAGR）为18.6%。在GE医疗和西门子医疗等公司在医院和影像中心部署人工智慧解决方案的推动下，该技术的应用正在迅速扩展。使用量以分析的影像检查数量来衡量。定价通常为每个解决方案每年1万美元到10万美元以上不等，具体取决于功能和规模。订阅模式和按收费模式都很常见。影像检查数量的增加以及对更快、更准确诊断的需求不断增长，正在推动该技术的应用和支出成长。

在放射学人工智慧市场中，软体占据主导地位，因为人工智慧驱动的演算法和平台构成了放射学解决方案的核心。这些软体工具能够实现影像的自动化分析、异常检测和临床决策支持，从而显着提高诊断准确度和工作流程效率。影像资料量的不断增长和熟练放射科医生的短缺是推动其应用的主要因素。虽然硬体支撑着诊断成像基础设施，服务保障着部署和维护，但由于人工智慧模型和整合能力的不断进步，软体仍然是主要的驱动力。

市场区隔
类型 软体、硬体和服务
服务 综合服务、维护服务、咨询服务、训练服务
科技 机器学习、深度学习、自然语言处理、电脑视觉
应用领域 肿瘤科、循环系统、神经科、肌肉骨骼系统科、呼吸系统科
实作方法 云端部署、本地部署、混合部署
最终用户 医院、诊断中心、研究机构
解决方案 诊断解决方案、基于影像的诊断解决方案、工作流程解决方案

在应用领域，肿瘤学占据主导地位，这主要得益于对早期精准癌症检测的迫切需求。人工智慧驱动的放射学解决方案被广泛应用于肿瘤识别、疾病进展监测和治疗方案製定。神经病学和心臟病学也是人工智慧的重要应用领域，人工智慧透过先进的影像分析技术辅助检测中风和心臟病等疾病。慢性病盛行率的不断上升以及对更快更精准诊断日益增长的需求，正在加速人工智慧在这些放射学应用领域的普及。

区域概览

北美凭藉其先进的医疗基础设施、高普及率的医学影像技术以及人工智慧与临床工作流程的深度融合，在放射学人工智慧市场占据最大份额。美国在该区域处于领先地位，其医院和诊断中心广泛使用人工智慧工具来解读CT、MRI和X光影像。随着领先的人工智慧医疗公司在北美市场的强大影响力以及对数位化医疗转型的巨额投资，人工智慧的应用正在加速发展。优惠的报销政策、高昂的医疗费用支出以及监管机构对人工智慧诊断工具的支持性核准，进一步巩固了北美在全球放射学人工智慧市场的主导地位。

亚太地区预计将成为放射学人工智慧市场中复合年增长率最高的地区，这主要得益于医疗系统的快速数位转型以及对高效诊断解决方案日益增长的需求。中国、印度、日本和韩国等国家正大力投资人工智慧驱动的医疗基础设施和医学影像技术。患者数量的增加、放射科医生的短缺以及慢性病患病率的上升，都在推动基于人工智慧的放射学工具的应用。政府支持智慧医院和远距放射学发展的倡议进一步加速了市场成长。此外，全球人工智慧公司和本地Start-Ups不断增加的投资也巩固了亚太地区作为成长最快区域市场的地位。

主要趋势和驱动因素

对更快、更准确的诊断影像的需求日益增长。

放射学领域人工智慧市场的主要驱动力是对更快、更准确、更有效率的诊断影像解决方案日益增长的需求。 CT、MRI 和 X 光扫描所获得的医学影像资料量不断增加，给放射科医生带来了沉重的负担，导致诊断延误和误诊。人工智慧驱动的放射学工具能够帮助实现影像分析自动化，更准确地侦测异常情况，并简化工作流程。这些技术尤其有助于肿瘤、神经系统疾病和心血管疾病的早期检测。慢性病盛行率的上升以及对预防医学需求的不断增长，进一步加速了全球医疗保健系统采用基于人工智慧的放射学解决方案。

扩展人工智慧诊断平台和远距放射诊断服务

人工智慧在放射学领域的一大机会在于人工智慧诊断平台和远距放射学服务的扩展。人工智慧与云端成像系统的融合，实现了即时分析和远距离诊断，从而改善了医疗资​​源匮乏地区的就医途径。远端医疗和数位化医院的日益普及，进一步推动了对人工智慧放射学工具的需求。此外，深度学习演算法和影像识别技术的进步也提高了诊断的准确性和效率。随着医疗服务提供者、人工智慧公司和影像设备製造商之间合作的不断加强，预计全球市场机会将显着成长。

目录

第一章：执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 软体
    • 硬体
    • 服务
  • 市场规模及预测：按解决方案划分
    • 诊断解决方案
    • 影像解决方案
    • 工作流程解决方案
  • 市场规模及预测：依服务划分
    • 综合服务
    • 维护服务
    • 咨询服务
    • 培训服务
  • 市场规模及预测：依技术划分
    • 机器学习
    • 深度学习
    • 自然语言处理
    • 电脑视觉
  • 市场规模及预测：依应用领域划分
    • 肿瘤学
    • 循环系统
    • 神经病学
    • 肌肉骨骼系统
    • 呼吸系统
  • 市场规模及预测：依市场细分
    • 基于云端的
    • 现场
    • 杂交种
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊断中心
    • 研究机构

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • IBM Watson Health
  • Zebra Medical Vision
  • Aidoc
  • Arterys
  • EnvoyAI
  • Fujifilm Holdings
  • Canon Medical Systems
  • Nuance Communications
  • iCAD
  • Riverain Technologies
  • Lunit
  • Qure.ai
  • Vuno
  • DeepMind
  • RadNet
  • Hologic
  • Butterfly Network

第九章 关于我们

简介目录
Product Code: GIS34515

The global AI in Radiology market is projected to grow from $32.0 billion in 2025 to $249.1 billion by 2035, at a compound annual growth rate (CAGR) of 18.6%. Adoption is growing rapidly, with increasing deployment of AI solutions across hospitals and imaging centers by companies like GE HealthCare and Siemens Healthineers. Usage is measured by the number of imaging studies analyzed. Pricing typically ranges from USD 10,000 to over USD 100,000 annually per solution, depending on features and scale. Subscription and per-scan pricing models are common. Rising imaging volumes and the need for faster, more accurate diagnostics are driving higher adoption and spending.

The Type segment in the AI in Radiology Market is dominated by software, as AI-driven algorithms and platforms form the core of radiology solutions. These software tools enable automated image analysis, anomaly detection, and clinical decision support, significantly improving diagnostic accuracy and workflow efficiency. The increasing volume of imaging data and the shortage of skilled radiologists are key factors driving adoption. While hardware supports imaging infrastructure, and services ensure implementation and maintenance, software remains the primary growth driver due to continuous advancements in AI models and integration capabilities.

Market Segmentation
TypeSoftware, Hardware, Services
ServicesIntegration Services, Maintenance Services, Consulting Services, Training Services
TechnologyMachine Learning, Deep Learning, Natural Language Processing, Computer Vision
ApplicationOncology, Cardiology, Neurology, Musculoskeletal, Respiratory
DeploymentCloud-Based, On-Premise, Hybrid
End UserHospitals, Diagnostic Centers, Research Institutes
SolutionDiagnostic Solutions, Imaging Solutions, Workflow Solutions

The Application segment is led by oncology, driven by the high demand for early and accurate cancer detection. AI-powered radiology solutions are widely used to identify tumors, monitor disease progression, and support treatment planning. Neurology and cardiology are also significant segments, where AI aids in detecting conditions such as stroke and heart disease through advanced imaging analysis. The growing prevalence of chronic diseases and the need for faster, more precise diagnostics are accelerating the adoption of AI in radiology across these application areas.

Geographical Overview

North America holds the largest market share in the AI in Radiology Market due to its advanced healthcare infrastructure, high adoption of medical imaging technologies, and strong integration of artificial intelligence in clinical workflows. The United States leads the region with widespread use of AI-powered tools in CT, MRI, and X-ray interpretation across hospitals and diagnostic centers. Strong presence of leading AI healthcare companies, combined with significant investments in digital health transformation, accelerates adoption. Favorable reimbursement structures, high healthcare expenditure, and supportive regulatory approvals for AI-based diagnostic tools further strengthen North America's dominant position in the global AI in radiology market.

Asia Pacific is expected to register the highest CAGR in the AI in Radiology Market due to rapid digitalization of healthcare systems and increasing demand for efficient diagnostic solutions. Countries such as China, India, Japan, and South Korea are investing heavily in AI-enabled healthcare infrastructure and medical imaging technologies. Rising patient populations, shortage of radiologists, and increasing prevalence of chronic diseases are driving adoption of AI-based radiology tools. Government initiatives supporting smart hospitals and tele-radiology expansion further accelerate growth. Additionally, growing investments from global AI companies and local startups are positioning Asia Pacific as the fastest-growing regional market.

Key Trends and Drivers

Rising demand for faster and more accurate diagnostic imaging

A key driver of the AI in Radiology Market is the increasing need for faster, more accurate, and efficient diagnostic imaging solutions. The growing volume of medical imaging data from CT, MRI, and X-ray scans is overwhelming radiologists, leading to delays and diagnostic errors. AI-powered radiology tools help automate image analysis, detect abnormalities with higher precision, and improve workflow efficiency. These technologies support early disease detection, particularly in oncology, neurology, and cardiovascular conditions. Rising prevalence of chronic diseases and increasing demand for preventive healthcare are further accelerating the adoption of AI-based radiology solutions across global healthcare systems.

Expansion of AI-enabled diagnostic platforms and teleradiology services

A major opportunity in the AI in Radiology Market lies in the expansion of AI-enabled diagnostic platforms and teleradiology services. The integration of artificial intelligence with cloud-based imaging systems allows real-time analysis and remote diagnosis, improving access to healthcare in underserved regions. Increasing adoption of telemedicine and digital hospitals is further driving demand for AI-powered radiology tools. Additionally, advancements in deep learning algorithms and image recognition technologies are enhancing diagnostic accuracy and efficiency. Growing collaborations between healthcare providers, AI companies, and imaging equipment manufacturers are expected to significantly expand market opportunities globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type (Software, Hardware, Services)
  • 2.2 Key Market Highlights by Solution (Diagnostic Solutions, Imaging Solutions, Workflow Solutions)
  • 2.3 Key Market Highlights by Services (Integration Services, Maintenance Services, Consulting Services, Training Services)
  • 2.4 Key Market Highlights by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision)
  • 2.5 Key Market Highlights by Application (Oncology, Cardiology, Neurology, Musculoskeletal, Respiratory)
  • 2.6 Key Market Highlights by Deployment (Cloud-Based, On-Premise, Hybrid)
  • 2.7 Key Market Highlights by End User (Hospitals, Diagnostic Centers, Research Institutes)

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software
    • 4.1.2 Hardware
    • 4.1.3 Services
  • 4.2 Market Size & Forecast by Solution (2020-2035)
    • 4.2.1 Diagnostic Solutions
    • 4.2.2 Imaging Solutions
    • 4.2.3 Workflow Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Integration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Consulting Services
    • 4.3.4 Training Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Deep Learning
    • 4.4.3 Natural Language Processing
    • 4.4.4 Computer Vision
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiology
    • 4.5.3 Neurology
    • 4.5.4 Musculoskeletal
    • 4.5.5 Respiratory
  • 4.6 Market Size & Forecast by Deployment (2020-2035)
    • 4.6.1 Cloud-Based
    • 4.6.2 On-Premise
    • 4.6.3 Hybrid
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Solution
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Deployment
      • 5.2.1.7 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Solution
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Deployment
      • 5.2.2.7 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Solution
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Deployment
      • 5.2.3.7 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Solution
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Deployment
      • 5.3.1.7 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Solution
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Deployment
      • 5.3.2.7 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Solution
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Deployment
      • 5.3.3.7 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Solution
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Deployment
      • 5.4.1.7 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Solution
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Deployment
      • 5.4.2.7 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Solution
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Deployment
      • 5.4.3.7 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Solution
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Deployment
      • 5.4.4.7 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Solution
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Deployment
      • 5.4.5.7 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Solution
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Deployment
      • 5.4.6.7 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Solution
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Deployment
      • 5.4.7.7 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Solution
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Deployment
      • 5.5.1.7 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Solution
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Deployment
      • 5.5.2.7 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Solution
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Deployment
      • 5.5.3.7 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Solution
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Deployment
      • 5.5.4.7 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Solution
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Deployment
      • 5.5.5.7 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Solution
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Deployment
      • 5.5.6.7 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Solution
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Deployment
      • 5.6.1.7 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Solution
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Deployment
      • 5.6.2.7 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Solution
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Deployment
      • 5.6.3.7 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Solution
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Deployment
      • 5.6.4.7 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Solution
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Deployment
      • 5.6.5.7 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Siemens Healthineers
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 GE Healthcare
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 IBM Watson Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zebra Medical Vision
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 EnvoyAI
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fujifilm Holdings
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Canon Medical Systems
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Nuance Communications
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 iCAD
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Riverain Technologies
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Qure.ai
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Vuno
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 DeepMind
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 RadNet
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Butterfly Network
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us